BackPeak Bio Overview

Peak Bio Current Assets

Track Peak Bio's current assets ($560) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$556.00
↓ 99.96% YoYΔ $-1.33M vs prior year quarter

Peer average

Loading

Peak Bio Current Assets History

Loading

Peak Bio vs. peers: Current Assets Comparison

Loading

Peak Bio Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Peak Bio (PKBO) FAQ

Peak Bio posts a current assets of $560 as of June 2025. That compares with $1.3M in the prior-year period — down 100.0% year over year. Comparing that reading with peers and prior periods is usually more useful than looking at the number in isolation.

In the prior comparable period, Peak Bio's current assets was $1.3M. The latest reading is $560 — a 100.0% year-over-year decrease (period ending June 2025). Use the history and growth charts on this page for a longer lookback.

Current Assets is one piece of Peak Bio's financial statement story. At $560, it should be interpreted next to related metrics — for example revenue with costs, assets with liabilities, or income with margins. Stockcircle links those related pages so you can move from this number to the surrounding context quickly.

Context for PKBO's current assets usually means three checks: (1) trend versus prior periods, (2) level versus peers, and (3) consistency with growth and profitability. This page covers the first two; Peak Bio's other metric pages and overview cover the third.